109 related articles for article (PubMed ID: 884662)
21. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
22. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma.
Urano M; Kim MS
Cancer Res; 1983 Jul; 43(7):3041-4. PubMed ID: 6850614
[TBL] [Abstract][Full Text] [Related]
23. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
[TBL] [Abstract][Full Text] [Related]
24. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
Ray PK; Raychaudhuri S
J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
[TBL] [Abstract][Full Text] [Related]
25. Importance of effective timing for combination treatment with chemotherapy and immunotherapy against a transplantable tumor in rats.
Gotohda E
Hokkaido Igaku Zasshi; 1977 May; 52(3):265-74. PubMed ID: 21133
[No Abstract] [Full Text] [Related]
26. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
27. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733
[TBL] [Abstract][Full Text] [Related]
28. Single-dose cyclophosphamide for the prevention of bladder tumor implantation in F344 rats: site of drug activity.
See WA; Crist SA; Williams RD
Cancer Res; 1991 Mar; 51(5):1378-83. PubMed ID: 1997176
[TBL] [Abstract][Full Text] [Related]
29. Detection of delayed hypersensitivity reaction in rats by radioisotopic footpad assay with sodium deoxycholate extract and mitomycin-C-treated tumor cells.
Yamada Y; Mizushima Y; Hosokawa M; Kobayashi H
Gan; 1978 Aug; 69(4):549-55. PubMed ID: 81787
[TBL] [Abstract][Full Text] [Related]
30. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
Li LH; Johnson MA; Moeller RB; Wallace TL
Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
[TBL] [Abstract][Full Text] [Related]
31. [Studies on lymphokine-activated killer (LAK) cell: accumulation in tumor tissue and the therapeutic effects of adoptive immunotherapy].
Wakizaka Y
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):475-87. PubMed ID: 1330859
[TBL] [Abstract][Full Text] [Related]
32. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
Xu ZY
Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
[TBL] [Abstract][Full Text] [Related]
33. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1982 Jun; 42(6):2211-5. PubMed ID: 7042079
[TBL] [Abstract][Full Text] [Related]
35. Successful immunotherapy of mouse melanoma and sarcoma with recombinant interleukin-2 and cyclophosphamide.
Silagi S; Schaefer AE
J Biol Response Mod; 1986 Oct; 5(5):411-22. PubMed ID: 3490544
[TBL] [Abstract][Full Text] [Related]
36. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.
Hengst JC; Mokyr MB; Dray S
Cancer Res; 1981 Jun; 41(6):2163-7. PubMed ID: 7016310
[TBL] [Abstract][Full Text] [Related]
37. Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamide.
Inagawa H; Ohshiro S; Nishizawa T; Goto S; Soma G; Mizuno D
Anticancer Res; 1997; 17(1A):55-60. PubMed ID: 9066630
[TBL] [Abstract][Full Text] [Related]
38. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.
Takeichi N; Koga Y; Fujii T; Kobayashi H
Cancer Res; 1985 Feb; 45(2):487-91. PubMed ID: 3871352
[TBL] [Abstract][Full Text] [Related]
39. Tumor regression in tumor-bearing mice by inoculations of immunogenic somatic hybrid cells in combination with cyclophosphamide.
Tachibana T; Dei T
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):455-63. PubMed ID: 6681341
[TBL] [Abstract][Full Text] [Related]
40. Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
Abe S; Takahashi K; Yamazaki M; Mizuno D
Jpn J Cancer Res; 1985 Jul; 76(7):626-30. PubMed ID: 3928559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
